Thus, we hypothesized that CD4+ cells and, in particular, the CD4+ CD28− subset could show a different degree of increased peripheral percentage in subjects with acute ischemic stroke in relation to clinical subtype and severity of ischemic stroke. The gene discussed is CD4; the disease is ischemic stroke.